结直肠癌腹膜癌患者术前CT可切除性与中期总生存的预测因素
研究纳入81例拟行肿瘤细胞减灭术联合腹腔热灌注化疗的结直肠癌腹膜癌患者,比较术前CT的腹膜癌指数(PCI)与开腹手术PCI评分。结果显示,放射学PCI≥20、肝周区域受累及广泛小肠受累是「开腹后仅行活检关闭」(O&C)的危险因素;左腹部区域受累与总生存期不良相关(HR 6.86,p<0.001)。结论认为,术前CT所见的腹膜癌分布部位与范围可预测可切除性和中期生存。
要点
- 术前CT的PCI评分≥20、肝周区域受累及广泛小肠受累与开腹后无法切除(O&C)相关。
- 左腹部区域受累与中期总生存期不良相关(HR 6.86,p<0.001)。
- 术前CT评估腹膜癌范围与部位有助于预测可切除性和中期生存。
核心结论
- 术前CT所见的腹膜癌分布部位与范围可预测可切除性和中期总生存。
研究设计与样本
- 研究纳入81例连续拟行肿瘤细胞减灭术联合腹腔热灌注化疗的结直肠癌腹膜癌患者,比较术前CT的PCI评分与开腹手术PCI评分,采用比值比、Cox比例风险回归模型和Kaplan-Meier生存分析评估可切除性(「开腹后仅行活检关闭」[O&C])和总生存期。
诊断标准与关键数值
- 放射学PCI评分≥20预测O&C的OR为20.61(p=0.001)。
- 肝周区域受累预测O&C的OR为3.63(p=0.047)。
- 广泛小肠受累预测O&C的OR为9.90(p=0.019)。
- 左腹部区域受累与总生存期不良相关,HR为6.86(p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To determine preoperative radiological findings that may correlate with resectability and medium-term overall survival (OS) in patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC).
MATERIALS AND METHODS: The study included 81 consecutive patients with PC scheduled for cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). PCI scores from preoperative computed tomography (CT) were compared with Peritoneal Cancer Index (PCI) scores at laparotomy. Odds ratio (OR), a Cox proportional hazards regression model, and Kaplan-Meier survival analyses were performed to evaluate resectability ("open and close procedure" [O&C]) and OS.
RESULTS: A radiological PCI score ≥20 (OR; 20.61 p=0.001), involvement of the perihepatic region (OR; 3.63, p=0.047) and extensive small bowel involvement (OR; 9.90, p=0.019) were risk factors for O&C. Involvement of the left abdominal region correlated adversely to OS (HR; 6.86, p<0.001).
CONCLUSIONS: The location of PC, in addition to the extent of PC as determined by preoperative CT, predicts resectability and medium-term survival.
引用
- Suzuki C, Wallgren H, Abraham-Nordling M, et al. Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer. Clin Radiol. 2018. PMID: 29678273. doi:10.1016/j.crad.2018.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。